DrugCite
Search

LAROXYL

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Laroxyl Adverse Events Reported to the FDA Over Time

How are Laroxyl adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Laroxyl, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Laroxyl is flagged as the suspect drug causing the adverse event.

Most Common Laroxyl Adverse Events Reported to the FDA

What are the most common Laroxyl adverse events reported to the FDA?

Fall
23 (2.55%)
Orthostatic Hypotension
17 (1.88%)
Confusional State
12 (1.33%)
Cytolytic Hepatitis
12 (1.33%)
Neutropenia
11 (1.22%)
Overdose
11 (1.22%)
Leukopenia
10 (1.11%)
Cholestasis
9 (1%)
Disturbance In Attention
9 (1%)
Extrapyramidal Disorder
9 (1%)
Hyponatraemia
9 (1%)
Show More Show More
Coma
8 (.89%)
Drug Exposure During Pregnancy
8 (.89%)
Renal Failure
8 (.89%)
Renal Failure Acute
8 (.89%)
Aspartate Aminotransferase Increase...
7 (.78%)
Balance Disorder
7 (.78%)
Drug Interaction
7 (.78%)
Dyspnoea
7 (.78%)
Gamma-glutamyltransferase Increased
7 (.78%)
Ileitis
7 (.78%)
Loss Of Consciousness
7 (.78%)
Malaise
7 (.78%)
Pancreatitis Acute
7 (.78%)
Somnolence
7 (.78%)
Vomiting
7 (.78%)
Alanine Aminotransferase Increased
6 (.67%)
Anaemia
6 (.67%)
Blood Bilirubin Increased
6 (.67%)
Condition Aggravated
6 (.67%)
Febrile Bone Marrow Aplasia
6 (.67%)
Hepatic Failure
6 (.67%)
Hypotension
6 (.67%)
Nausea
6 (.67%)
Suicide Attempt
6 (.67%)
Tremor
6 (.67%)
Aggression
5 (.55%)
Anxiety
5 (.55%)
Asthenia
5 (.55%)
Blood Creatine Phosphokinase Increa...
5 (.55%)
Cardiac Failure
5 (.55%)
Epilepsy
5 (.55%)
Hyperhidrosis
5 (.55%)
Hyperlactacidaemia
5 (.55%)
Hypoxia
5 (.55%)
International Normalised Ratio Incr...
5 (.55%)
Multiple Drug Overdose Intentional
5 (.55%)
Road Traffic Accident
5 (.55%)
Thrombocytopenia
5 (.55%)
Catatonia
4 (.44%)
Chills
4 (.44%)
Convulsion
4 (.44%)
Delirium
4 (.44%)
Drug Withdrawal Syndrome Neonatal
4 (.44%)
Factor Ii Deficiency
4 (.44%)
Factor V Deficiency
4 (.44%)
Factor Vii Deficiency
4 (.44%)
General Physical Health Deteriorati...
4 (.44%)
Heart Rate Increased
4 (.44%)
Hepatitis Fulminant
4 (.44%)
Hyperkalaemia
4 (.44%)
Hyperthermia
4 (.44%)
Intestinal Obstruction
4 (.44%)
Pericardial Effusion
4 (.44%)
Platelet Count Decreased
4 (.44%)
Pleural Effusion
4 (.44%)
Pulmonary Embolism
4 (.44%)
Sudden Death
4 (.44%)
Urinary Retention
4 (.44%)
Abdominal Pain
3 (.33%)
Abnormal Behaviour
3 (.33%)
Agitation
3 (.33%)
Arrhythmia
3 (.33%)
Arthralgia
3 (.33%)
Atrial Fibrillation
3 (.33%)
Blood Pressure Increased
3 (.33%)
Blood Triglycerides Increased
3 (.33%)
C-reactive Protein Increased
3 (.33%)
Cholelithiasis
3 (.33%)
Clinodactyly
3 (.33%)
Deep Vein Thrombosis
3 (.33%)
Drug Ineffective
3 (.33%)
Dysmorphism
3 (.33%)
Faecaloma
3 (.33%)
Hallucination, Visual
3 (.33%)
Hypoalbuminaemia
3 (.33%)
Hypokalaemia
3 (.33%)
Hypotonia Neonatal
3 (.33%)
Inflammation
3 (.33%)
Intentional Overdose
3 (.33%)
Interstitial Lung Disease
3 (.33%)
Jaundice Neonatal
3 (.33%)
Liver Function Test Abnormal
3 (.33%)
Myoclonus
3 (.33%)
Neonatal Respiratory Distress Syndr...
3 (.33%)
Neuroleptic Malignant Syndrome
3 (.33%)
Osteonecrosis
3 (.33%)
Pallor
3 (.33%)
Pancreatic Disorder
3 (.33%)
Parkinsonism
3 (.33%)
Peripheral Ischaemia
3 (.33%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Laroxyl, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Laroxyl is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Laroxyl

What are the most common Laroxyl adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Laroxyl, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Laroxyl is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Laroxyl According to Those Reporting Adverse Events

Why are people taking Laroxyl, according to those reporting adverse events to the FDA?

Drug Use For Unknown Indication
98
Depression
60
Pain
18
Neuralgia
15
Product Used For Unknown Indication
13
Anxiety
12
Show More Show More
Dysthymic Disorder
8
Facial Neuralgia
5
Cancer Pain
4
Agitation
4
Ill-defined Disorder
4
Headache
3
Tension Headache
3
Sciatica
3
Depressive Symptom
3
Pain In Extremity
3
Premedication
2
Periarthritis
2
Back Pain
2
Bipolar I Disorder
2
Dysaesthesia
2
Mental Disorder
2
Neuropathy
2
Sleep Disorder
2
Neuropathy Peripheral
2
Major Depression
2
Insomnia
2
Polyneuropathy
2
Prophylaxis
1
Hyperaesthesia
1
Autonomic Neuropathy
1
Chest Pain
1
Drug Exposure During Pregnancy
1
Intentional Overdose
1
Impulsive Behaviour
1
Neoplasm Malignant
1
Analgesic Therapy
1
Panic Attack
1
Overdose
1
Psychotic Disorder
1
Psychomotor Hyperactivity
1
Somnolence
1
General Physical Health Deteriorati...
1
Facial Palsy
1
Neuropathic Pain
1
Keratitis
1

Laroxyl Case Reports

What Laroxyl safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Laroxyl. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Laroxyl.